Security key
81577F406
SEELOS THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (SEELQ)
CUSIP: 81577F406
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 38,673
- Total 13F value
- $145,219
- Share change
- +38,319
- SEC-reported price per share
- $3.76
- Number of holders
- 14
- Value change
- +$143,890
- Number of buys
- 13
- Shares outstanding
- 581,045
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2024
Institutions
14
Top holders
10
SEELQ full security history
Ownership snapshot
Full 13F holder table
SEELOS THERAPEUTICS, INC. SEC filings
SEELOS THERAPEUTICS, INC. company facts
Broader feeds
Ownership snapshot
Top reported holders of SEELQ - SEELOS THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Raj Mehra
Disclosed value leader
Raj Mehra
Comparable rows
0/8
Latest evidence
30 Jun 2024
3/4/5
13F
Highest disclosed value: $114,418
8 rows are not safely comparable across share classes.
Showing 1-6 of 8 holder rows.
Quick read
Raj Mehra has the largest disclosed position value at $114.4K.
0 of 8 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Raj Mehra's linked filing trail.
Disclosed position value
Top 4
Raj Mehra
$114.4K
Michael Joseph Golembiewski
$95.3K
HOLLENCREST CAPITAL MANAGEMENT
$6
Parallel Advisors, LLC
$2
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 8 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Raj Mehra |
3/4/5
President, Chief Executive Officer and Chairman of the Board of Directors, Director
|
—
mixed-class rows
|
$114,418
331,282 shares
mixed-class rows
|
— | 12 Jan 2024 |
| Michael Joseph Golembiewski |
3/4/5
Chief Financial Officer
|
—
mixed-class rows
|
$95,295
111,406 shares
mixed-class rows
|
— | 29 Feb 2024 |
| HOLLENCREST CAPITAL MANAGEMENT |
13F
Company
|
—
class O/S missing
|
$6
10 shares
|
— | 30 Jun 2024 |
| Parallel Advisors, LLC |
13F
Company
|
—
class O/S missing
|
$2
3 shares
|
— | 30 Jun 2024 |
| Brian Lian |
3/4/5
Director
|
—
class O/S missing
|
—
1,666 shares
|
— | 04 Jan 2024 |
| Daniel J. O'Connor |
3/4/5
Director
|
—
class O/S missing
|
—
1,666 shares
|
— | 04 Jan 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
14
Shares
38,673
Rows available
14
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
0
Q3 2024 holders
14
Holder diff
14
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|